Epidemiological Status of Mycobacterium ulcerans Infections in Togo, 2010 - 2015

Menssah Teko¹, Mounerou Salou², Yaovi-Gameli Afanyibo³, Ebekalisai Piten¹, Abiba Banla Kere³ and Yaovi Ameyapoh^4,

¹Centre Hospitalier Régional de Tsévié, Tsévié, Togo

²Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo

³Institut National d’Hygiène, Lomé, Togo

⁴Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Superieure des Techniques Biologiques et Alimentaires, Université de Lomé, Lomé, Togo

Cite this paper:
Menssah Teko, Mounerou Salou, Yaovi-Gameli Afanyibo, Ebekalisai Piten, Abiba Banla Kere and Yaovi Ameyapoh. Epidemiological Status of Mycobacterium ulcerans Infections in Togo, 2010 - 2015. American Journal of Epidemiology and Infectious Disease. 2019; 7(1):6-10. doi: 10.12691/ajeid-7-1-2

Abstract

Buruli ulcer is a mycobacterial disease caused by Mycobacterium ulcerans. The infection affects skin through the production of an exotoxin that causes necrosis of hypodermic fat. Children are the main target of the infection. In Togo, some data are available. This article is a report of the epidemiological situation in the five regions of Togo between 2010 and 2015. Three hundred and fifty-three (353) cases were reported. The Maritime Region, especially Zio District, is the location where most of the cases were recorded. It appears that in-depth studies must be carried out to understand the factors of the elevated numbers of Buruli ulcer cases in the Maritime Region.

Keywords:
Buruli ulcer epidemiology epidemiological status Togo Sub-Saharan Africa

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Portaels F (1995). Epidemiology of mycobacterial diseases. Available from: http://dspace.itg.be/handle/10390/5407
[2]	Nakanaga K, Yotsu RR, Hoshino Y, Suzuki K, Makino M, Ishii N (2013). Buruli ulcer And mycolactone-producing mycobacteria. Jpn J Infect Dis., 66(2), 83-88.
[3]	WHO (2017). Buruli ulcer (Mycobacterium ulcerans infection) Fact sheet N°199 Available from: http://www.who.int/mediacentre/factsheets/fs199/en/.
[4]	Mac Callum P, Tolhurst JC, Buckle G, Sissons HA (1948). A new mycobacterial infection in man. J Pathol., 1, 60(1), 93-122.
[5]	Clancey JK, Dodge OG, Lunn HF, Oduori ML (1981). Mycobacterial skin ulcers in Uganda. The Lancet, 278(7209), 951-954.
[6]	Josse R, Guedenon A, Aguiar J, Anagonou S, Zinsou C, Prost C, et al. (1994). L’ulcère de Buruli, une pathologie peu connue au Bénin: à propos de 227 cas. In: Bulletin de la Société de pathologie exotique. Springer; 170-175. Available from: http://cat.inist.fr/?aModele=afficheN&cpsidt=3381374
[7]	Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH (1993). Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg., 87(6), 644-645.
[8]	Kanga JM, Kacou ED (1990). Aspects épidémiologiques de l’ulcère de Buruli en Côte d’Ivoire: résultats d’une enquête nationale. Bulletin de la Societe de pathologie exotique, 94(1), 46-51.
[9]	Goutzamanis JJ, Gilbert GL (1995). Mycobacterium ulcerans infection in Australian children: report of eight cases and review. Clin Infect Dis., 21(5), 1186-1192.
[10]	Faber WR, Arias-Bouda LM, Zeegelaar JE, Kolk AH, Fonteyne PA, Toonstra J, et al. (2000). First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg., 94(3), 277-279.
[11]	Tsukamura M, Kaneda K, Imaeda T, Mikoshiba H (1989). A taxonomic study on a mycobacterium which caused a skin ulcer in a Japanese girl and resembled Mycobacterium ulcerans. Kekkaku., 64(11), 691-697.
[12]	De Gentile PL, Mahaza C, Rolland F, Carbonnelle B, Verret JL, Chabasse D (1982). Cutaneous ulcer from Mycobacterium ulcerans. Apropos of 1 case in French Guiana. Bull Soc Pathol Exot., 85(3), 212-214.
[13]	McGann H, Stragier P, Portaels F, Gascoyne Binzi D, Collyns T, Lucas S, et al. (2009) Buruli ulcer in United Kingdom tourist returning from Latin America. Emerging Infect Dis., 15(11), 1827-1829.
[14]	dos Santos VM, Noronha FL, Vicentina EC, Lima CC (2007). Mycobacterium ulcerans infection in Brazil. Med J Aust., 2; 187(1), 63-64.
[15]	Meyers WM, Tignokpa N, Priuli GB, Portaels F (1996). Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. British journal of dermatology. 134(6), 1116-1121.
[16]	Aguiar J, Domingo MC, Guédénon A, Meyers W, Steunou C, Portaels F (1997). L’ulcère de Buruli, une maladie mycobactérienne importante et en recrudescence au Bénin. Bull Séances Acad R Sci Outre Mer., (3), 325-356.
[17]	Christinet V, Di Benedetto C, Comte E, Calmy A (2012). Buruli et VIH: une interaction complexe et peu étudiée. Revue médicale suisse., 8(354), 1792-1793.
[18]	Walsh DS, Portaels F, Meyers WM (2008). Buruli ulcer (Mycobacterium ulcerans infection). Transactions of the Royal Society of Tropical Medicine and Hygiene., 102(10), 969-978.
[19]	Johnson RC, Sopoh GE, Boko M, Zinsou C, Gbovi J, Makoutode M, et al (2005). Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin. Trop Med Int Health., 10(9): 863-871.
[20]	Vincent QB, Ardant M-F, Adeye A, Goundote A, Saint-André J-P, Cottin J, et al (2014). Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. Lancet Glob Health., 2(7), e422-430.
[21]	Porten K, Sailor K, Comte E, Njikap A, Sobry A, Sihom F, et al (2009). Prevalence of Buruli Ulcer in Akonolinga Health District, Cameroon: Results of a Cross Sectional Survey. PLOS Neglected Tropical Diseases., 23; 3(6), e466.
[22]	Ukwaja KN, Meka AO, Chukwuka A, Asiedu KB, Huber KL, Eddyani M, et al (2016). Buruli ulcer in Nigeria: results of a pilot case study in three rural districts. Infect Dis Poverty. 5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841952/.
[23]	Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, Asiedu K, et al (2002). Buruli Ulcer in Ghana: Results of a National Case Search. Emerg Infect Dis., 8(2), 167-170.
[24]	Mavinga Phanzu D, Suykerbuyk P, Saunderson P, Ngwala Lukanu P, Masamba Minuku J-B, Imposo DBB, et al (2013). Burden of Mycobacterium ulcerans Disease (Buruli Ulcer) and the Underreporting Ratio in the Territory of Songololo, Democratic Republic of Congo. PLoS Negl Trop Dis., 7(12). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855042/
[25]	Lagarrigue V, Portaels F, Meyers WM, Aguiar J (2000). Buruli ulcer: risk of bone involvement! A propos of 33 cases observed in Benin. Med Trop., 60(3), 262-266.
[26]	Beissner M, Arens N, Wiedemann F, Piten E, Kobara B, Bauer M, et al (2015). Treatment Outcome of Patients with Buruli Ulcer Disease in Togo. PLoS Negl Trop Dis., 9(10). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608783/.
[27]	Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, Herbinger K-H, et al (2011). Laboratory confirmation of Buruli ulcer disease in Togo, 2007–2010. PLoS Negl Trop Dis., 5(7), e1228.
[28]	Eddyani M, Portaels F (2007). Survival of Mycobacterium ulcerans at 37 degrees C. Clin Microbiol Infect., 13(10), 1033-1035.
[29]	Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Scott JT, et al (2004). Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health., 9(12), 1297-1304.
[30]	Stoffel V, Barthelmé B, Chagué F (2005). Écopathologie tropicale: ulcère de Buruli par Monts et par vaux. Santé Publique., 17(2), 191-197.